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Elucidation of the Complete Azorhizobium Nicotinate 
Catabolism Pathway 
Department ofBiology, Sinsheimer Laboratories, University of California, Santa Croz, California 95064 
A complete pathway for Azorhizobium coulinotlans nicotinate catabolism has been determined from mutant 
phenotype analyses, isolation of metabolic intermediates, and structural studies. Nicotinate serves as a 
respiratory electron donor to O2 via a membrane-bound hydroxylase and a specific c-type eytochrome oxidase. 
The resulting oxidized product, 6-hydroxynicotinate, is next reduced to 1,4,S,6-tetrahydro-6-oxonicotinate. 
Hydrolytic ring breakage foUows, with release of pyridine N as ammonium. Decarboxylation then releases the 
nicotinate C-7 carboxyl group as CO2 , and the remaining C skeleton is then oxidized to yield g1utarate. 
Transthioesterification with succinyl coenzyme A (succinyl-CoA) yields g1utaryl-CoA, which is then oxidatively 
decarboxylated to yield crotonyl-CoA. As with general acyl ~ oxidation, L-~-hydroxybutyryl-CoA,acetoacetyl­
CoA, and finally two molecules of acetyl-CoA are produced. In sum, nicotinate is catabolized to yield two CO2 
molecules, two aceiy(-CoA molecules, and ammonium. Nicotinate catabolism stimulates Azorhizobium N2 
fixation rates in culture. Nicotinate catabolism mutants stm able to Uberate pyridine N as ammonium retain this 
capability, whereas mutants so blocked do not. From, mutant analyses and additional physiological tests, N2 
fixation stimulation is indirect. In N-Iimited culture, nicotinate catabolism augments anabolic N pools and, as 
a consequence, yields N2-ftxing ceUs with higher dinitrogenase content. 
Azorhizobium caulinodans invades both stems and roots 
of the host legume Sesbania rostrata and yields symbiotic 
nodules that fix N2 at very high rates. All wild Azorhizobium 
isolates are phenotypically indistinguishable and are auxo­
trophic for pyridine nucleotide cofactor (NAD+) biosynthe­
sis; culture in defined medium requires nicotinate supple­
mentation (10). When so cultured, A. caulinodans also uses 
nicotinate as the sole N source for growth (22). Whereas all 
other studied rhizobia exclusively fix N2 in symbiosis, A. 
caulinodans avidly fixes N2 in culture (10). Paradoxically, 
when fixing N2 in culture under optimal conditions, A. 
caulinodans exhaustively catabolizes nicotinate, and its 
growth becomes NAD+ limited. Relative to a submicromo­
lar nicotinate vitamin requirement, high-level (0.3 mM) 
nicotinate supplementation strongly stimulates N2 fixation in 
culture (4,11). We have sought to understand how nicotinate 
stimulates N2 fixation. 
Although nicotinate is a good N source, it is a poor C 
source for Azorhizobium growth (18). However, stoichio­
metric measurements of nicotinate-stimulated O2 consump­
tion indicate that A. caulinodans completely utilizes the 
nicotinate C skeleton (18). Cyclic intermediates in this 
pathway were previously isolated and characterized, and a 
mechanism of pyridine ring N release was proposed (18) 
(Fig. 1). Nicotinate is first oxidized to yield 6-hydroxynico­
tinate by a membrane-bound hydroxylase, which uses O2 as 
an electron acceptor. The nicotinate-specific respiratory 
chain to O2 terminates at a c-type cytochrome oxidase (17). 
The reaction product, 6-hydroxynicotinate, is next reduced 
to form 1,4,5,6-tetrahydro-6-oxonicotinate (THON) by a 
soluble dehydrogenase activity (18). As with the obligate 
anaerobe Clostridium barkeri (14, 28), the THON pyridine 
ring is next cleaved, and ammonium is released, by hydro­
lysis with two water equivalents. Further catabolic steps in 
the two bacteria then diverge. C. barkeri ferments nicoti­
nate, undertaking a complex C-skeleton rearrangement with­
out decarboxylation, to yield pyruvate and propionate (28). 
A. caulinodans, as described here, catabolizes THON by 
utilizing two oxidative decarboxylations to yield acetyl co­
enzyme A (acetyl-CoA) (Fig. 1). 
Azorhizobium insertion mutants with altered nicotinate 
hydroxylase activity were previously isolated by screening 
for candidates unable to use nicotinate as an N source 
(Nic[N] phenotype). These mutants were then subclassified 
according to their ability to use 6-hydroxynicotinate as an N 
source (6HN[N] phenotype) (4, 18). When nicotinate levels 
in N2-fixing batch cultures were increased from 16 J.1.M to 0.3 
mM, all Azorhizobium Nic[N] - strains, in contrast to the 
wild type, showed no stimulation of dinitrogenase activity. 
However, for Nic[Nr the 6HN[N)+ mutants, dinitrogenase 
activity was fully stimulated when 0.3 mM 6-hydroxynicoti­
nate was added to these cultures. In contrast, N2 fixation by 
6HN[Nr mutants did not respond to 6-hydroxynicotinate 
supplementation (4). Therefore, stimulation of N2 fixation 
correlates with a nicotinate catabolism event(s) subsequent 
to 6-hydroxynicotinate production and not with nicotinate 
hydroxylase-driven respiration. 
As reported here, Azorhizobium mutants affected in distal 
steps of the nicotinate catabolic pathway nevertheless con­
duct abortive nicotinate catabolism, release pyridine N as 
ammonium, and remain able to grow on nicotinate as an N 
source. These mutants fix N2 with wild-type physiological 
properties. From these and other experiments, by inference, 
nicotinate catabolism indirectly stimulates N2 fixation by 
augmenting steady-state anabolic N pools in N-limited cul­
ture. 
MATERIALS AND MEmODS 
Bacterial strains, mutant isolations, and growth media. A. 
caulinodans wild-type strain 57100 (9) was mutagenized by 
the vector insertion (Vi) technique as previously described 
(8); a random spectrum of mutants was obtained (7). A 
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FIG. 1. The Azorhizobium nicotinate catabolic pathway. Intermediates in brackets are inferred from the data presented; not all
intermediates may be released as free, diffusible compounds (18).
library of 600,000 random Vi mutants was screened for
inability to use either DL-,-hydroxybutyrate or 6-hydroxyni-
cotinate as a C source (,BHB- or 6HN[C]- phenotype).
Candidates that remained able to grow with succinate as a C
source on plates were purified and retested for C-source
utilization in defined liquid medium. Defined growth medium
consisted of minimal salts (basal medium) supplemented
with 20 mM C source and 10 mM N source (4). C sources
tested were succinate, glutarate, 6-hydroxynicotinate, DL-i-
hydroxybutyrate, acetoacetate, and acetate; N sources
tested were glutamate, ammonium, nicotinate, and 6-hy-
droxynicotinate.
Physiological radiolabeling studies. Bacterial strains were
cultured in basal medium with succinate as a C source and
glutamate as an N source; cells were harvested by centrifu-
gation and washed once in P7 buffer (7 mM potassium
phosphate buffer [pH 7.0]) and diluted in 80 mM phosphate
buffer [pH 7.0] to an A600 of 0.4. Samples (5 ml) were added
to serum vials containing 1-ml 1 M NaOH wells, and
physiological labeling was initiated with 0.1 mM [7-14CJnic-
otinate (0.7 ,uCi umol-1). Serum vials were incubated for 3 h
at 30°C on a rotary shaker, brought to pH 1.0 with 0.2 ml
concentrated H2SO4, and further shaken for 6 to 8 h. Both
cell suspension-assimilated 14C and unincorporated, trapped
14C were then counted by Cerenkov scintillation, and frac-
tional assimilation was determined.
SGCT and GCADH assays. Cultures in mid-exponential
growth phase were harvested by centrifugation, washed
once in P7 buffer, concentrated 100-fold, and lysed by
ultrasonication. Unbroken cells were removed by centrifu-
gation, and total protein in cell extracts was determined by
the method of Bradford as described elsewhere (1). Reac-
tions were carried out in 1-ml cuvettes containing 50 mM
Tris-Cl (pH 8.0), 2 mM ferricyanide, 10 mM sodium cyanate,
and 50 ,ul of cell extract. Glutaryl-CoA dehydrogenase
(GCADH) activity was recorded as 2 mM glutaryl-CoA
(Sigma Chemical Co.)-dependent decrease in A420. Succi-
nate:glutarate-CoA transferase (SGCT) activity was assayed
similarly, with 0.5 mM succinyl-CoA (Sigma) added. Activ-
ity was recorded as 10 mM glutarate-dependent decrease in
A420.
Dinitrogenase assays. Bacteria were cultured to early ex-
ponential growth phase in defined liquid basal medium
supplemented with the indicated C and N sources (see text)
under 21% 02, washed, and then resuspended in NIF (4)
medium under 3% 02; N2 fixation is optimum in these
conditions (4). After cultures were fully induced (8 to 10 h),
stoppered vials were injected with acetylene to 0.01 atm by
using a gas-tight syringe. Ethylene production was measured
at time zero and hourly for 3 h by gas chromatography (4),
and data were extrapolated to infer initial velocities. Light
scattering (A6.) by induced cultures was also measured, and
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TABLE 1. A. caulinodans Nic- Vi mutants and their phenotypes
Phenotype
Straina
6HN[N] 6HN[C] deCO2 Glr ,BHB Aac Ace
57100 (wild type) + + + + + + +
Mutants
61606 (5) + + + + +
61604 + + + + +
61607 + + + + +
61612 + + + + +
61618 + + + + +
61505 (3) + + + + + +
61504 + + + + + +
61509 + + + + + +
61510 (4) + + + + +
61515 + + + + +
63077 (5) + + +
63083 (16) + +
a Nicotinate mutant strains are divided by phenotypic subclass, with the
archetype strain listed first. All mutants carry single VP2021 insertions.
Numbers of independent mutants are listed in parentheses.
b Wild-type [7-14Clnicotinate decarboxylase activity.
absorbances were converted to cells per milliliter by inter-
polation with a standard curve of light scattering (A6.)
versus viable cell count.
RESULTS
Isolation of Azorhizobium PHB- or 6HC[CF- mutants. An
A. caulinodans 57100 library carrying random, single
VP2021 insertions (Materials and Methods) was screened for
candidates unable to use DL-0-hydroxybutyrate as a C
source for growth; 21 independent mutants were identified
(Table 1). All 21 mutants unable to utilize racemic DL-0-
hydroxybutyrate also proved unable to utilize 6-hydroxyni-
cotinate as a C source. These mutants implicate distal steps
in nicotinate catabolism, as discussed below. The same
library, minus the DL-p-hydroxybutyrate mutant candidates,
was further screened for derivatives unable to utilize 6-hy-
droxynicotinate as a C source (6HN[C]-). Those candidates
also unable to use 6-hydroxynicotinate as an N source
(6HN[N]-) were identified and disregarded. Twelve inde-
pendent candidates resulted; all proved able to use both
nicotinate and 6-hydroxynicotinate as the sole N source
(Nic[N]+ 6HN[N]+) but unable to use 6-hydroxynicotinate
as a C source (6HN[C]-). All mutants were then categorized
by ability to grow on four C sources: acetate, acetoacetate,
DL-fi-hydroxybutyrate, and glutarate (Table 1). All 6HN[C]-
mutants unable to use acetate as a C source (Ace-) could use
neither acetoacetate (Aac-) nor glutarate (Glr-) as a C
source. Similarly, all Aac- Ace' mutants also proved to be
Glr-. Four independent Glr- Aac+ Ace' mutants were
identified (Table 1). Compared with the wild type, the
remaining eight mutants all used the four C sources nor-
mally. These mutants were eventually subclassified by anal-
ysis of their decarboxylase activities, as discussed below.
All 6HN[C]- Aac+ mutants remained able to use both
D-,-hydroxybutyrate and L- 3-hydroxybutyrate as C
sources.
During its catabolism, nicotinate suffers decarboxylative
loss of the C-7 carboxyl group. Eight 6HN[N]+ 6HN[C]-
TABLE 2. Azorhizobium physiological radiolabeling
with [7-14C]nicotinate
Strain Phenotype % "CO2 released'
57100 Wild type 97
61309 6HN[Nf- 16
61604 6HN[N]+ 6HN[C]- 56
61606 6HN[N]+ 6HN[C]- 44
61607 6HN[N]+ 6HN[C]- 58
61612 6HN[N]+ 6HN[C]- 56
61618 6HN[N]+ 6HN[C]- 54
61505 6HN[N]+ 6HN[C]- 96
61504 6HN[N]+ 6HN[C]- 97
61509 6HN[N]+ 6HN[C]- 96
61510 6HN[N]+ Glr- 98
a Percent total radiolabel recovered as CO2 (Materials and Methods).
Glr+ mutants were tested for ability to release 14CO2 from
[7-14C]nicotinate (Materials and Methods). As it is unable to
break the nicotinate ring (4), 6HN[N]- strain 61309 was
included as a deficient experimental control. Strain 61510
(6HN[N]+ 6HN[C]- Glr-) and wild-type strain 57100 were
also included as proficient experimental controls. For all
samples, percentage total 14C02 released and trapped as
sodium carbonate was determined by scintillation spectrom-
etry (Table 2; Materials and Methods). Conditioned growth
media of all strains except strain 61309 showed no UV
absorbance at 257 nm above background. Thus, nicotinate
was exhausted at the end of the experiment. Because strain
61309 cultures accumulate THON in growth media and lack
THON hydrolase activity (18), the small amount of 14C02
produced by strain 61309 may reflect an acid-labile THON
carboxyl group. Five of the eight 6HN[N]+ 6HN[C]- Glr+
mutants released less than 60% of added [7-14C]nicotinate as
14C02; the three other mutants released more than 95%.
Unfortunately, no 6HN[N]+ 6HN[C]- mutant tested re-
tained more than 60% of the [7-14C]nicotinate label. As
discussed below, hydrolysis of THON with concomitant
ammonium release yields 2-formylglutarate (2FG) (28). Be-
cause the experimental media were acidified to volatilize
C02, any produced 2FG might undergo spontaneous decar-
boxylation of its C-1 carboxyl group (corresponding to
nicotinate C-7) at appreciable rates. Correspondingly, 14C02
release from [7-14C]nicotinate would inevitably be substan-
tial relative to that observed with strain 61309, in which ring
breakage does not occur. Because they released less than
60% of total [7-14C]nicotinate as 14C02, these six mutants
may be unable to enzymatically decarboxylate nicotinate.
2FG might suffer either of two catabolic fates: it might be
decarboxylated to yield glutaryl semialdehyde and then
oxidized to yield glutarate, or it might be oxidatively decar-
boxylated to directly yield glutarate. While we attempted to
distinguish between these two possibilities, we could neither
obtain nor synthesize glutaryl semialdehyde. In either case,
if glutarate were produced by nicotinate catabolism, then
6HN[N]+ Glr- mutant cultures might accumulate glutarate
in conditioned media.
6-Hydroxynicotinate catabolism yields glutarate. Strain
61510 (Glr-) was cultured at 30°C with vigorous aeration in
defined liquid medium with 20 mM acetate as the C source
and 10 mM 6-hydroxynicotinate as the N source. After
reaching stationary phase, cultures were centrifuged, and
the supernatant was recovered and filtered. Conditioned
medium was acidified to pH 1 with Dowex 50W-X8 resin
(H+ form), which removed 6-hydroxynicotinate, and twice
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FIG. 2. Proton nuclear magnetic resonance spectrum of the
crystalline compound purified from conditioned medium of strain
61510 culture. The sample was dissolved in chloroform. Except for
the [1H]chloroform solvent signal used to calibrate the scale, no
down-field signals were present.
extracted (1:1 by volume) with ethyl acetate. The organic
phase was collected and air dried overnight; this procedure
removed residual acetic acid. The resulting white residue
was resuspended in ethyl acetate, and insoluble material was
removed by centrifugation. Upon addition of hexanes, crys-
tals (12 mg) were obtained. The crystalline precipitate was
collected by centrifugation, washed with hexane, and air
dried. UV scanning spectrophotometry indicated that ap-
proximately 1% 6-hydroxynicotinate and THON remained in
the resulting crystalline powder (data not presented). The
nuclear magnetic resonance spectrum of the crystals was
obtained and proved identical with that reported for glutaric
acid (Fig. 2) (26). Infrared absorption spectra and mass
spectra of the crystals were also obtained (data not present-
ed); results were also consistent with those obtained for ACS
reagent glutaric acid (Sigma).
By contrast, supernatant fractions from strain 61510 cul-
tured on ammonium as the N source did not accumulate
glutarate. Therefore, glutarate is produced by catabolism of
6-hydroxynicotinate.
Glutarate is transthioesterified to yield glutaryl-CoA, which
is then oxidized by a respiratory dehydrogenase complex.
Wild-type A. caulinodans was cultured in defined medium
with several C sources; cell extracts were then assayed for
respiratory GCADH activity, using glutaryl-CoA as an elec-
tron donor and ferricyanide as an electron acceptor (Mate-
rials and Methods); neither NAD+ nor methylene blue
served as an electron acceptor for glutaryl-CoA oxidation.
GCADH activity was strongly induced when culture media
were glutarate supplemented. With succinate as the C source,
GCADH activity in wild-type cell extracts was 1/10 of that
observed with glutarate as the C source (Table 3). Repre-
sentative 6HN[C]- mutants were similarly tested for GCADH
activity. When cultured in defined medium with acetate as the
C source and 6-hydroxynicotinate as the N source, all strains
showed GCADH activities at wild-type levels.
Glutarate-dependent thioacylation of coenzyme A
(CoASH) was tested by a coupled assay. AlthoughAzorhizo-
bium cell-free extracts exhibited a short-lived, glutarate-
dependent ferricyanide reduction, glutaryl-CoA-dependent
TABLE 3. Azorhizobium GCADH and SGCT activities
Activity (nmol
of ferricyanide
reduced min-
Strain Phenotype mg of
protein-1)
GCADH SGCr
57100 cultured in BASAL medium Wild type
with:
20 mM succinate + 10 mM NH4' 4.3 ND
20 mM glutarate + 10 mM NH4' 47 34
20 mM acetate + 10 mM 6- 21 14
hydroxynicotinate
61606a 6HN[N]+ 18 12
6HN[C]
61505a 6HN[N]+ 13 7.0
6HN[C]-
61510a 6HN[N]+ Glr- 16 0.55
61515a 6HN[N]+ Glr- 17 0.38
a Cultured in basal medium with 20 mM acetate and 10 mM 6-hydroxynic-
otinate.
ferricyanide reduction was sustained for more than 10 min at
high rates. In glutarate-dependent assays, neither millimolar
ATP addition nor millimolar CoASH addition nor both
sustained ferricyanide reduction. However, millimolar suc-
cinyl-CoA stimulated ferricyanide reduction rates 50%, and
high rates were sustained for at least 10 min (data not
presented). Thus, A. caulinodans forms glutaryl-CoA by
transthioesterification with succinyl-CoA. Representative
Azorhizobium mutants were then assayed for SGCT activity
as both glutarate- and succinyl-CoA-dependent ferricyanide
reduction (Materials and Methods). In crude extracts of cells
cultured on acetate and 6-hydroxynicotinate, strains 57100
(wild type), 61505, and 61606 showed comparable SGCT
activities, whereas Glr- mutants 61510 and 61515 showed
greatly reduced SGCT activities (Table 3).
Azorhizobium mutants unable to use DL-P-hydroxybutyrate
as a source of acetoacetyl-CoA cannot use 6-hydroxynicotinate
as a C source. When tested in liquid culture with defined
medium, wild-type A. caulinodans grew on either D- or
L-13-hydroxybutyrate as the sole C source. From Line-
weaver-Burk plots, two NAD+-dependent 3-hydroxybu-
tyrate dehydrogenase activities were kinetically distin-
guished in crude extracts of wild-type cells cultured with
racemic DL-P-hydroxybutyrate as the C source; the two
dehydrogenase activities specifically oxidized each of the
two 1-hydroxybutyrate enantiomers. As with the closely
related Alcaligenes eutrophus (27), however, free D-p-hy-
droxybutyrate was oxidized to acetoacetate, while L-1-
hydroxybutyrate was first thioacylated to form L-p-hydroxy-
butyryl-CoA, which was then oxidized to acetoacetyl-CoA
(21). We thus inferred that Azorhizobium catabolism of
racemic DL-p-hydroxybutyrate would converge at ace-
toacetyl-CoA, which is optically inactive. Similarly, ace-
toacetyl-CoA is a Pseudomonas glutarate catabolism inter-
mediate (25). As discussed above, 21 independent
Azorhizobium Vi mutants unable to utilize racemic DL-,-
hydroxybutyrate as the sole C source (Table 1) were tested
to delimit convergence ofAzorhizobium nicotinate and DL-
P-hydroxybutyrate pathways. All 21 mutants were Aac-.
Wild-type cells cultured on DL-j3-hydroxybutyrate as the C
source showed high levels of both acetoacetate:succinate-
CoA transferase and 1-ketothiolase activities (21). Because
the wild type efficiently converted acetoacetate to ace-
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TABLE 4. Azorhizobium dinitrogenase activities in culture
Acetylene reduction ratea
Strain Phenotype
No supplement Nicotinate Valine
57100 Wild type 1.0 2.3 2.1
61302 6HN[N]- 0.9 1.1 2.1
61606 6HN[N]+ 1.1 2.4 NT
6HN[C]-
61505 6HN[N]+ 1.2 2.4 NT
6HN[C]-
61510 6HN[N]+ Glr- 1.3 2.6 NT
63077 6HN[N]+ PHB- 1.0 2.3 NT
63083 6HN[N]+ Aac- 1.5 3.1 NT
a In NIF medium (4) supplemented with 16 FM nicotinate and 0.3 mM
compounds indicated by the phenotypes. Values are normalized both for
viable cell counts and for wild-type strain 57100 rates without supplementa-
tion. Data are mean values of three parallel experiments (standard errors of
<15%). NT, not tested.
toacetyl-CoA, these 21 mutants must therefore be unable to
use acetoacetyl-CoA. Only five mutants were able to grow
on acetate as the sole C source (Table 1). Because the
remaining 16 mutants grew normally on succinate as the sole
C source, they were presumably affected in either or both
glyoxylate bypass reactions catalyzed by isocitrate lyase and
L-malate synthetase (19).
Most importantly, all 21 mutants were 6HN[C]- Glr-
Nic[N]+. Thus, acetoacetyl-CoA is indeed an intermediate
in nicotinate catabolism, and as with conventional 1-ke-
toacyl oxidations, Azorhizobium nicotinate catabolism ter-
minates with conversion of crotonyl-CoA to acetoacetyl-
CoA and then to two acetyl-CoA molecules. We may thus
posit a complete pathway for Azorhizobium nicotinate ca-
tabolism (Fig. 1).
Nicotinate catabolism stimulates N2 fixation by augmenting
anabolic N pools. Under optimum physiological conditions,
both nicotinate and 6-hydroxynicotinate stimulated wild-
type Azorhizobium dinitrogenase rates threefold (Table 4).
This stimulation was substrate concentration dependent and
was optimal at 0.3 mM supplementation of either compound.
As these physiological conditions entail steady-state N lim-
itation, the wild type rapidly and exhaustively catabolizes
nicotinate as a secondary N source (4, 11). To study physi-
ological coupling of nicotinate catabolism and N2 fixation,
Azorhizobium 6HN[C]- mutants representative of each phe-
notypic subclass were assayed for dinitrogenase activity at
various times after a physiological shift to N2 fixation
(Materials and Methods). Strain 61302, a nicotinate hydrox-
ylase mutant in which N2 fixation is not stimulated by added
nicotinate (4), was included as a deficient experimental
control. For both the wild-type and all 6HN[N]+ 6HN[C]-
mutants tested, when induction media were supplemented
with 0.3 mM nicotinate, N2 fixation rates were highly stim-
ulated (Table 4). This mutant class seems to have an abortive
nicotinate catabolism, which both produces ammonium for
use as an N source and excretes C-skeleton intermediates,
including glutarate. Consequently, ammonium is produced
at rates sufficient for use as an anabolic N source but
insufficient to create steady-state N excess, which would
inhibit N2 fixation.
Because this abortive nicotinate catabolism both stimu-
lated Azorhizobium N2 fixation and released limiting ammo-
nium as an anabolic N source, these two processes might be
physiologically coupled. Accordingly, we tested another
Azorhizobium secondary N source for ability to stimulate N2
fixation in culture. In wild-type defined liquid cultures,
L-valine served satisfactorily as an N source but not as a C
source. Therefore, the wild type and strain 61302 were
cultured in defined medium with succinate as the C source,
0.3 mM L-valine as the N source, and limiting (16 pM)
nicotinate as a vitamin. L-Valine mimicked nicotinate, stim-
ulating N2 fixation rates by both strains twofold (Table 4).
Moreover, strain 57611, an ammonium assimilation mutant
defective in L-glutamate synthase activity (5, 6), grew nor-
mally on L-valine as an N source. Hence, L-valine is tran-
saminated, presumably by L-leucine aminotransferase, to
directly yield L-glutamate, and not ammonium, as an ana-
bolic N source. Thus, stimulation of N2 fixation correlated
with a general increase in steady-state anabolic N pools
rather than with a specific increase in endogenous ammo-
nium.
Therefore, nicotinate catabolism stimulates Azorhizobium
N2 fixation by augmenting anabolic N pools. When optimally
fixing N2 in culture with excess succinate as a C source, A.
caulinodans catabolizes nicotinate at high rates yet remains
physiologically N limited. As a consequence of nicotinate-
released ammonium, A. caulinodans may sustain higher
anabolic rates, and thus higher dinitrogenase biosynthetic
rates, without suffering excess ammonium-mediated, feed-
back-inhibitory effects on N2 fixation. By contrast, although
Azorhizobium nicotinate catabolism presupposes both nico-
tinate- and glutaryl-CoA-driven respiratory oxidations, ac-
tivity of neither respiratory chain correlates with N2 fixation
capability.
DISCUSSION
Azorhizobium nicotinate catabolism, at least up to ring
breakage, is a chimera of two inferred pathways. As with all
bacteria investigated (2, 13, 28), nicotinate is first oxidized to
6-hydroxynicotinate. Isolated nicotinate hydroxylases from
Pseudomonas and Bacillus spp. both contain c-type cy-
tochromes (15, 16). Similarly, one class of Azorhizobium
Nic[N]- mutant lacks all c-type cytochromes (17, 18). Like
its fellow aerobes, A. caulinodans channels electrons from
the nicotinate hydroxylase complex through a cytochrome
c-containing respiratory chain to 02.
6-Hydroxynicotinate suffers different fates in different
organisms. Surprisingly, as does C. barkeri (27), A. caulin-
odans next reduces 6-hydroxynicotinate to yield THON,
which then undergoes hydrolytic ring breakage. In C. bark-
eri, the first intermediate identified subsequent to ring break-
age was 2-methyleneglutarate. The inferred initial ring
breakage product was 2-formylglutaryl-5-amide, produced
by hydrolysis across the N-1-C-6 bond. Amide hydrolysis of
2-formylglutaryl-5-amide would then yield 2FG. In C. bark-
en, nicotinate fermentation proceeds with the reduction of
2FG to yield 2-methyleneglutarate (28). In A. caulinodans,
as reported here, [7-14C]nicotinate was stoichiometrically
converted to "4CO2, and the first identified intermediate
subsequent to ring breakage was glutarate. In contrast to the
C. barken fermentative pathway,A. caulinodans oxidatively
decarboxylates 2FG to yield glutarate. Indeed, this oxidative
decarboxylation may be the only nicotinate catabolic reac-
tion unique to A. caulinodans.
In patching together a nicotinate catabolic pathway with
reactions taken from both anaerobes and aerobes, A. cauli-
nodans, an obligate aerobe, avoids soluble dioxygenase
reactions employed by fellow aerobes Pseudomonas and
Bacillus spp. (2, 13). As A. caulinodans avidly catabolizes
nicotinate during N2 fixation, to which cytosolic 02 would
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pose a dire threat, its steady-state cytosolic 02 level may be
insufficient to facilitate reaction with soluble dioxygenases.
Uniquely, A. caulinodans converts nicotinate to glutarate,
whose breakdown has also been studied in other aerobes. In
Pseudomonas fluorescens, glutarate is thioesterified with
free CoASH and, in an ATP-dependent reaction, yields
glutaryl-CoA (24). By contrast, A. caulinodans employs
glutarate and succinyl-CoA as cosubstrates in a thioacyl-
transferase (SGCT) reaction. Strains 61510 and 61515
showed sharply reduced SGCT activity, which correlated
with a 6HN[C]- Glr- phenotype. The wild type also exhib-
ited GCADH activity, which in P. fluorescens yields croto-
nyl-CoA (25). Indeed, Azorhizobium GCADH activity was
induced by both glutarate and 6-hydroxynicotinate. Al-
though not demonstrated, Azorhizobium GCADH activity
presumably also yields crotonyl-CoA (Fig. 1). Then, as with
archetypal acyl i oxidation, crotonyl-CoA hydrolase and
L-3-hydroxybutyryl-CoA dehydrogenase, in concert, pro-
duce acetoacetyl-CoA, which then reacts with free CoASH
via p-ketothiolase to yield two acetyl-CoA molecules. From
mutant phenotypic and enzyme analyses reported here, this
pathway operates similarly inA. caulinodans. Indeed, when
growing on nicotinate as the sole C and N sources the wild
type strongly induces glyoxylate bypass activity, indicative
of steady-state acetyl-CoA excess (21).
If A. caulinodans were to produce acetyl-CoA from glu-
tarate, then Aac- Ace' mutants would also be Glr-. From a
total of 33 6HN[N]+ 6HN[C]- random insertion mutants, we
subclassified sixteen Glr- Aac- mutants and five Glr- Aac-
Ace' mutants. Therefore, A. caulinodans and P. fluorescens
catabolize glutaryl-CoA similarly. In sum, A. caulinodans
catabolizes nicotinate to yield ammonium, two CO2 mole-
cules, and two acetyl-CoA molecules.
Because it requires nicotinate for NAD+ synthesis, and
because under optimum N2-fixing physiological conditions it
rapidly catabolizes nicotinate as an N source, the wild-type
Azorhizobium strain is not a true diazotroph (22). In
Azorhizobium N2-fixing chemostat cultures, less than 10% of
the assimilated N culture yield was estimated as derived
from nicotinate N; more than 90% was derived from fixed N2
(3, 12). Therefore, N2-fixing, N-limited continuous culture
yields are only marginally affected by increased nicotinate,
yet in batch culture, nicotinate is exhausted and NAD+
becomes growth limiting (11). However, in both continuous
and batch cultures, increased nicotinate indeed correlates
with increased dinitrogenase activity (4, 12). By contrast,
for either Azorhizobium Nic[N]- or 6HN[N]- mutants, in-
creased nicotinate supplementation did not stimulate N2 fix-
ation. Hence, any physiological coupling with N2 fixation
involves nicotinate catabolism, not pyridine nucleotide bio-
synthesis. When nicotinate hydroxylase (Nic[N]- 6HN[N]+)
mutants are supplemented with increased 6-hydroxynicoti-
nate, N2 fixation is highly stimulated (4). Indeed, Azorhizo-
bium 6HN[N]+ 6HN[C]- mutants fix N2 at wild-type rates,
and N2 fixation rates also respond to increased nicotinate.
If ammonium released by nicotinate catabolism stimulates
N2 fixation, would not ammonium added to N2-fixing cul-
tures effect the same outcome? To a very limited extent, yes.
While 0.05 mM ammonium does slightly stimulate N2-fixing
batch cultures, at higher levels, ammonium strongly inhibits
N2 fixation (21). As with many diazotrophs, ammonium
mediates transcriptional repression, covalent modification,
allosteric inhibition, and product inhibition of dinitrogenase,
all of which mitigate N2 fixation (20, 23).
In Azorhizobium cultures, when nicotinate is further in-
creased above 0.3 mM, N2 fixation is inhibited (4). There-
fore, 0.3 mM may be the exogenous nicotinate level that
allows endogenous ammonium release at steady-state rates
approximating those of prevailing ammonium assimilation.
As a consequence, intracellular steady-state ammonium
pools are low and insufficient to inhibit N2 fixation. Never-
theless, under steady-state N limitation, higher ammonium
assimilation rates imply higher dinitrogenase biosynthesis
rates. When cultured with excess succinate as a C source,
nicotinate, 6-hydroxynicotinate, or L-valine may be supplied
as an N source at exogenous levels up to 0.3 mM and yet
maintain endogenous steady-state N limitation. Still, ana-
bolic rates of bacteria in N-limited cultures will respond to
increases in endogenous anabolic N. In addition, after phys-
iological shift of exponential-phase Azorhizobium cultures
(or any other diazotrophic bacterial culture) to N-free me-
dium, much net anabolism is dinitrogenase biosynthesis.
Therefore, a subtle increase in steady-state anabolic N pools
may profoundly affect N2 fixation capacity.
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